Abiopharma

Clinical trial NCT07552558 updates: 1. start date: 2026-06-30 → 2026-09-30 2. completion date: 2033-08-31 → 2033-11-30 3. primary completion date: 2028-08-31 → 2028-11-30

Clinical trial NCT07593092 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-30

Clinical trial NCT03409432: collaborators added: Celgene Corporation.

Clinical trial NCT07265258 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-30 → 2026-07-30 3. completion date: 2027-09-04 → 2028-12-30 4. primary completion date: 2026-09-12 → 2028-06-30

Odysight.ai Reports Financial Results for the First Half of 2026 and Provides Business Update

Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

Odysight.ai signs agreement with Boeing to demonstrate AI-Powered capabilities

SuperCom Reports Record Revenue and Record EBITDA of $4 Million in the Second Quarter of 2026

ARX Stock Alert: Halper Sadeh LLC is Investigating Whether Accelerant Holdings is Obtaining a Fair Price for its Shareholders

Ideal Power Reports Second Quarter 2026 Financial Results